Results 71 to 80 of about 1,136 (121)

Willingness to Undergo Gastroscopy for Early Gastric Cancer Screening and Its Associated Factors During the COVID-19 Pandemic – A Nationwide Cross-Sectional Study in China

open access: yesPatient Preference and Adherence, 2023
Kejia Ma,1,2 Xuejie Chen,1,2 Xin Xiang,3 Xueyi Mao,3 Ningxin Zhu,1,2 Tianyu Wang,1,2 Shuyu Ye,1,2 Xiaoyan Wang,1,2,* Minzi Deng1,2,* 1Department of Gastroenterology, The Third Xiangya Hospital of Central South University, Changsha, Hunan, People ...
Ma K   +8 more
doaj  

Dose of remimazolam in painless gastroenteroscopy in elderly patients under bispectral index monitoring

open access: yesZhongguo linchuang yanjiu
Objective To explore the appropriate initial dose of remimazolam for painless gastroenteroscopy in elderly patients based on bispectral index (BIS) monitoring.
WANG Bohua*, LIU Fengzhi, LI Ximing
doaj   +1 more source

Safety and Efficacy of Oliceridine Combined with Propofol for Painless Gastroscopy: A Single-Center, Randomized, Parallel Controlled Clinical Trial

open access: yesDrug Design, Development and Therapy
Xuping Hu, Chunyuan Yang, Jun Li, Fuping Wang, Hongjiang You, Changchun Chen, Leyu JiangDepartment of Anesthesiology, Dazhou Central Hospital, Dazhou, People’s Republic of China*These authors contributed equally to this workCorrespondence: Leyu ...
Hu X   +6 more
doaj  

Determination of the 90% effective dose of propofol combined with oliceridine or fentanyl for inhibiting the insertion response in upper gastrointestinal endoscopy: a dose-finding trial

open access: yesFrontiers in Medicine
BackgroundPropofol combined with opioids is commonly used for procedural sedation, enhancing patient tolerance and reducing the incidence of adverse events. This study aimed to determine the 90% effective dose (ED90) of propofol combined with fentanyl or
Fangsheng Xu   +10 more
doaj   +1 more source

UEG Week 2024 Poster Presentations

open access: yes
United European Gastroenterology Journal, Volume 12, Issue S8, Page 665-1360, October 2024.
wiley   +1 more source

The median effective dose of ciprofol combined with a low-dose sufentanil for gastroscopy in obese or nonobese patients: a dose-finding study using Dixon’s up-and-down method

open access: yesFrontiers in Pharmacology
ObjectivesUnderstanding the different pharmacodynamic responses to narcotics in patients with or without obesity is particularly important for the safety of gastroscopy sedation.
Jie Zhao   +7 more
doaj   +1 more source

Opioid type, rather than liver function, is associated with postoperative nausea and vomiting after painless gastroscopy in decompensated cirrhosis

open access: yesFrontiers in Pharmacology
BackgroundPostoperative nausea and vomiting (PONV) is common after painless gastroscopy. The independent predictive value of preoperative albumin, total bilirubin, Apfel score, and opioid type for PONV in decompensated cirrhosis is unknown.ObjectiveIn ...
Xiao-Yu Gu   +3 more
doaj   +1 more source

Sedative efficacy and safety of remimazolam tosylate in painless gastroscopy diagnosis and treatment

open access: yesZhongguo linchuang yanjiu
Objective To compare the differences in efficacy and safety between remimazolam tosylate and propofol for sedation during painless gastroscopy, and its effect on awakening time and discharge time.
SONG Gaixia   +4 more
doaj   +1 more source

Effects of low-dose esketamine on hypoxemia during gastroscopy in patients with moderate-to-high risk obstructive sleep apnea: protocol for a prospective, randomized, controlled trial

open access: yesTrials
Background Propofol sedation in patients with Obstructive Sleep Apnea (OSA) frequently induces hypoxemia, posing significant clinical risks. Esketamine, an N-Methyl-D-Aspartate (NMDA) receptor antagonist, may reduce propofol requirements while preserving
Xin-Ming Li   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy